Current Edition

Passive or Active? Supply chain leaders compare key pharmaceutical cold chain technologies in latest white paper

The vital role that temperature-controlled packaging plays in transporting pharmaceuticals around the world has been highlighted in a new white paper from Tower Cold Chain, with the aim of helping stakeholders find the right solution for their needs.

Compounded by the demands of the COVID-19 pandemic, the white paper provides practical advice on the various options available, with insight delivered by seven leading industry experts from across the supply chain. These include senior decision-makers from Johnson & Johnson, DHL and LOT Polish Airlines, who deliver an unbiased guide that is ideal for specifiers in pharmaceuticals, 3PL and air freight looking to make informed choices.

Free to download from the Tower website, the white paper – titled Passive v Active in a globally disrupted age – collates the key findings of a 90-minute webinar organised by Tower in late 2021. Amongst the topics covered are the rapid changes affecting the industry; the new challenges that are arising in delivering vaccines to remote areas; and the considerations that must be made in selecting the optimum container type for the task.

At the heart of the publication is an assessment of the relative merits of Active, Passive and Hybrid temperature-controlled packaging solutions with detailed insight on their use across the global pharmaceutical supply chain.

In an unbiased review of the technologies, the white paper identifies a place for all types of temperature-controlled solutions within the market.

“In some circumstances, active methods are ideal. In others, passive is the only sensible choice to de-risk the shipment,” explains Kevin Doran, Global Head of Supply Chain at Tower Cold Chain.

“When it comes to patient care and the effective delivery of critical pharmaceuticals there’s no benefit in being partisan. We felt it was vital that decision-makers can get a balanced view, which is why this white paper brings together a wide range of voices to survey the whole landscape and identify the scenarios for the best use of each technology.

“We’re grateful to all of the experts who gave their time and provide such a rich source of insight and information – and we look forward to sharing it with others.”

The white paper can be downloaded here.

About Tower

www.towercoldchain.com

Tower delivers proven physical and temperature protection for pharmaceutical and life science products and our robust, reliable and reusable containers are the essential link in the stability of the cold chain.

Headquartered in the UK, we operate a global network ensuring availability and easy access to our products for all customers.

We are trusted by global pharmaceutical, logistics and airline companies and our experienced team, supported by a centralised quality-management system, reinforces customer confidence that our shipping facilities will meet requirements throughout the supply chain. Our patented design technology ensures our solutions meet the pharmaceutical industry performance standard, providing a minimum of 120 hours temperature compliance in any environment, anywhere in the world.

We work closely with our customers, realising their requirements and how we can address emerging needs. and to deliver customer-focused innovation in temperature controlled protection.

For Tower sales enquiries please contact:

Nick Gilmore, Global Head of Sales & Marketing

Email:  Nick.Gilmore@towercoldchain.com

For Tower media enquiries please contact:

Simon Wildash or Rhiannon Hopper, Nielsen McAllister

Tel: +44 (0)1332 293939
Email: tower@nmpr.co.uk